Centre d'Estudis Epidemiològics sobre les ITS i Sida de Catalunya

You are here

Publicacions 2013 | CEEISCAT

Publicacions 2013

 
 
Oliva J, Díez M, Galindo S, Cevallos C, Izquierdo A, Cereijo J, Arrilaga A, Nicolau A, Fernández A, Álvarez M, Castilla J, Martínez E, López I, Vives N. Determinantes de enfermedad avanzada y presentación tardía en los nuevos diagnósticos de VIH notificados al sistema de vigilancia epidemiológica en España. Gac Sanit. 2013 Dec 20. pii: S0213-9111(13)00137-4. doi: 10.1016/J.gaceta.2013.06.009. [Epub ahead of print]
 
Folch C, Fernández-Dávila P, Ferrer L, Soriano R, Díez M, Casabona J. Conductas sexuales de alto riesgo en hombres que tienen relaciones sexuales con hombres según tipo de pareja sexual. Enferm Infecc Microbiol Clin. 2013 Nov 15. doi:pii: S0213-005X(13)00305-4. 10.1016/j.eimc.2013.09.017. [Epub ahead of print]
 
Puertas MC, Massanella M, Llibre JM, Ballestero M, Buzon MJ, Ouchi D, Esteve A, Boix J, Manzardo C, Miró JM, Gatell JM, Clotet B, Blanco J, Martinez-Picado J; the MaraviBoost Collaborative Group. Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection. AIDS. 2013 Oct 30. [Epub ahead of print]
 
May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, D'Arminio Monforte A, Casabona J, Hogg RS, Mocroft A, Lampe FC, Dabis F, Fätkenheuer G, Sterling TR, Del Amo J, Gill MJ, Crane HM, Saag MS, Guest J, Brodt HR, Sterne JA; the Antiretroviral Cohort Collaboration. Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). Int J Epidemiol. 2013 Apr 18. [Epub ahead of print]
 
Stuardo V, Agustí C, Casabona J; HPV-PISCIS Study Group. Low Prevalence of Cervical Cancer Screening Among HIV-Positive Women in Catalonia (Spain).  J Aids Clin Res 2013 S3: 004. . doi:10.4172/2155-6113.S3-004.

 
Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD; for the Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD. The Incidence of AIDS-Defining Illnesses at a Current CD4 Count >=200 Cells/μL in the Post-Combination Antiretroviral Therapy Era. Clin Infect Dis. 2013 Oct;57(7):1038-47. doi: 10.1093/cid/cit423

 
Marcus U, Hickson F, Weatherburn P, Schmidt AJ; the EMIS Network. Estimating the size of the MSM populations for 38 European countries by calculating the survey-surveillance discrepancies (SSD) between self-reported new HIV diagnoses from the European MSM internet survey (EMIS) and surveillance-reported HIV diagnoses among MSM in 2009.  BMC Public Health. 2013 Oct 3;13:919. doi: 10.1186/1471-2458-13-919.
 
González V, Gomes-Fernandes M, Bascuñana E, Casanovas S, Saludes V, Jordana-Lluch E, Matas L, Ausina V, Martró E. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice. J Clin Virol. 2013 Sep;58(1):249-53. doi: 10.1016/j.jcv.2013.05.005. Epub 2013 Jun 2.
 
Marcus U, Hickson F, Weatherburn P, Schmidt AJ; the EMIS Network. Age biases in a large HIV and sexual behaviour-related internet survey among MSM.  BMC Public Health. 2013 Sep 10;13:826. doi: 10.1186/1471-2458-13-826.
 
Vickerman P, Martin NK, Roy A, Beattie T, Jarlais DD, Strathdee S, Wiessing L, Hickman M; EMCDDA Collaborative Group. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?  Drug Alcohol Depend. 2013 Sep 1;132(1-2):172-81.  doi: 10.1016/j.drugalcdep.2013.01.020. Epub 2013 Feb 28.

 
Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord. Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510. doi: 10.1371/journal.pmed.1001510. Epub 2013 Sep 3.

 
Agustí C, Fernàndez-López L, Mascort J, Carrillo R, Aguado C, Montoliu A, Puigdangolas X, De la Poza M, Rifà B, Casabona J.  Attitudes to rapid HIV testing among Spanish general practitioners. HIV Med. 2013;14(Suppl. 3):53–6. doi: 10.1111/hiv.12055.
 
Fernández Dávila P, Folch C, Ferrer L, Soriano R, Díez M, Casabona J. Who are the men who have sex with men in Spain that have never been tested for HIV?. HIV Med. 2013;14(Suppl.3):44-8.doi: 10.1111/hiv.12060
 
Agustí C, Fernàndez L, Mascrot J, Carrillo R, Casabona J; Grupo de Trabajo del Diagnóstico Precoz del VIH en Atención Primaria en España. Barreras para el diagnóstico de las Infecciones de Transmisión Sexual y VIH en Atención Primaria en España. Enferm Infecc Microbiol Clin. 2013 Aug-Sep;31(7):451-4. doi: 10.1016/j.eimc.2012.12.012. 
 
Saludes V, Bascuñana E, Jordana-Lluch E, Casanovas S, Ardèvol M, Soler E, Planas R, Ausina V, Martró E. Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients. PLoS One. 2013 Aug 28;8(8):e72600. doi: 10.1371/journal.pone.0072600.
 
Vives N, Lugo R, Lopez E, Garcia de Olalla P, Minguell S, Barrabeig I, Pons P, Lopez-Grado E, Ferre I, Escriche R, Armengol P, Vall M, Soler P, Leon I, Gascon I, Vicente A, Falguera G, Avecilla-Palau A, Martinez C, Barbera M, Gonzalez V, Cayla J, Casabona J. Increase in gonorrhoea among very young adolescents, Catalonia, Spain, January 2012 to June 2013. Euro Surveill. 2013 Aug 15;18(33). pii: 20560.
 
Lahuerta M, Torrens M, Sabidó M, Batres A, Casabona J. Sexual risk behaviours and barriers to HIV testing among clients of female sex workers in Guatemala: a qualitative study. Cult Health Sex. 2013 Aug;15(7):759-73. doi: 10.1080/13691058.2013.777474.
 
Folch C, Lazar C, Ferrer L, Sanclemente C, Casabona J. Female sex workers and access to social and health services in Catalonia: influence of region of origin and place of work. AIDS Care. 2013 Aug;25(8):1033-8. doi: 10.1080/09540121.2012.748872.
 
Folch C, Casabona J, Espelt A, Majó X, Meroño M, Gonzalez V, Brugal MT; REDAN Study Group. Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain. Gac Sanit. 2013 Jul-Aug;27(4):338-43. doi: 10.1016/j.gaceta.2013.02.006.
 
Saludes V, Esteve M, Casas I, Ausina V, Martró E. Hepatitis C virus transmission during colonoscopy evidenced by phylogenetic analysis. J Clin Virol. 2013 Jul;57(3):263-6. doi: 10.1016/j.jcv.2013.03.007. Epub 2013 Apr 6.
 
Casabona J. Bajo el volcán. Med Clin (Barc). 2013 Jul 7;141(1):37-39. doi: 10.1016/j.medcli.2013.02.028.
 
Tuneu MJ, Vallès X, Carnicer-Pont D, Barberá MJ, Godoy P, Avecilla-Palau A, Jordà B, Lopez-Grado E, Rivero D, Vives A, Acera A, Almirall R, Crespo N, Casabona J; the Partner Notification Study Group. Pilot study to introduce a notification card for partner notification of sexually transmitted infections in Catalonia, Spain, June 2010 to June 2011. Euro Surveill. 2013 Jul 4;18(27):pii=20516.
 
Manzardo C, Esteve A, Ortega N, Podzamczer D, Murillas J, Segura F, Force L, Tural C, Vilaró J, Masabeu A, Garcia I, Guadarrama M, Ferrer E, Riera M, Navarro G, Clotet B, Gatell JM, Casabona J, Miro JM; PISCIS Cohort Investigators. Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort. Clin Microbiol Infect. 2013 Jul;19(7):646-53. doi: 10.1111/j.1469-0691.2012.03991.x.
 
Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA; Writing committee for the Antiretroviral Cohort Collaboration. Insurability of HIV positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies. AIDS. 2013 Jun 19;27(10):1641-55 . doi: 10.1097/QAD.0b013e3283601199.
 
The Antiretroviral Therapy Cohort Collaboration (ART-CC). Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe and the United States.Clin Infect Dis. 2013 Jun;56(12):1800-9. doi: 10.1093/cid/cit111.
 
Massanella M, Esteve A, Buzón MJ, Llibre JM, Puertas MC, Gatell JM, Domingo P, Stevenson M, Clotet B, Martinez-Picado J, Blanco J; the IntegRal collaborative group. Dynamics of CD8 T-Cell Activation after Discontinuation of HIV Treatment Intensification. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):152-160.doi: 10.1097/QAI.0b013e318289439a.
 
Gomes Naveca F, Sabidó M, Amaral Pires de Almeida T, Araújo Veras E, Contreras Mejía Mdel C, Galban E, Benzaken AS. Etiology of genital ulcer disease in a sexually transmitted infection reference center in manaus, Brazilian Amazon. PLoS One. 2013 May 21;8(5):e63953.doi: 10.1371/journal.pone.0063953. Print 2013.
 
Antiretroviral Therapy Cohort Collaboration (ART-CC), Shepherd BS, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR. Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis. AIDS. 2013 May 15;27(8):1321-9. doi: 10.1097/QAD.0b013e32835faa95.
 
Weatherburn P, Schmidt AJ, Hickson F, Reid D, Berg RC, Hospers HJ, Marcus U; the EMIS Network. The European men-who-have-sex-with-men Internet survey (EMIS): design and methods. Sex Res Soc Policy. 2013 May 7. doi: 10.1007/s13178-013-0119-4.
 
Agustí C,  Fernàndez-López L, Mascort J, Carrillo R, Aguadod C, Montoliu A, Puigdengolasc X, De La P oza M, Rifà B, Casabona J. Acceptability of rapid HIV diagnosis technology among primary healthcare practitioners in Spain. AIDS Care. 2013 May;25(5):544-9. doi: 10.1080/09540121.2012.726339.
 
Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). Predictors of CD4+ T-Cell Counts of HIV Type 1-Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes. J Infect Dis. 2013 Mar;207(5):759-67. doi: 10.1093/infdis/jis752.
 
Jordana-Lluch E, Carolan HE, Giménez M, Sampath R, Ecker DJ, Quesada MD, Mòdol JM, Arméstar F, Blyn LB, Cummins LL, Ausina V, Martró E. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLoS One. 2013 Apr 23;8(4):e62108. . doi: 10.1371/journal.pone.0062108. Print 2013.
 
 
Jordana-Lluch E, Carolan HE, Giménez M, Sampath R, Ecker DJ, Quesada MD, Mòdol JM, Arméstar F, Blyn LB, Cummins LL, Ausina V, Martró E. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLoS One. 2013 Apr 23;8(4):e62108. . doi: 10.1371/journal.pone.0062108. Print 2013.
 
Antiretroviral Therapy Cohort Collaboration (ART-CC). Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009. AIDS. 2013 Mar 13;27(5):803-13. doi: 10.1097/QAD.0b013e32835cb997.
 
Ross MW, Berg RC, Schmidt AJ, Hospers HJ, Breveglieri M, Furegato M, Weatherburn P; European MSM Internet Survey (EMIS) Network. Internalised homonegativity predicts HIV-associated risk behavior in European men who have sex with men in a 38-country cross-sectional study: some public health implications of homophobia. BMJ Open. 2013 Feb 4;3(2). pii: e001928. doi: 10.1136/bmjopen-2012-001928.
 
Saludes V, González-Candelas F, Planas R, Solà R, Ausina V, Martró E. Evolutionary dynamics of the E1-E2 viral populations during combination therapy in non-responder patients chronically infected with hepatitis C virus subtype 1b. Infect Genet Evol. 2013 Jan;13:1-10. doi: 10.1016/j.meegid.2012.09.012. Epub 2012 Sep 26.